Diabetes mellitus responds better to co-formulated tablet dosages of dapagliflozin (DFZN), metformin (MFMN), and vildagliptin (VDGN). For the purpose of studying stability and quantifying DFZN, VDGN, and MFMN in bulk forms and in dosage forms, an efficient and fast HPLC method of analysis is currently developed. The mobile phase featured 80:20 (v/v) 0.2 M, pH 3.0, ammonium acetate buffer and acetonitrile mixed together and Luna's HPLC C-18 column, named Phenyl hexyl, was utilised for DFZN, VDGN, and MFMN separation and its quantification. The PDA type detector operating at 235 nm wavelength was deployed. The “International Conference on Harmonisation” recommendations were strictly adhered throughout the validation process. A strong linear association between response and quantity in the range of 2.5–15 µg/ml (DFZN), 25–150 µg/ml (VDGN), and 125–750 µg/ml (MFMN) is supported by the regression information for the DFZN, VDGN, and MFMN calibration plots. The precision, selectivity, accuracy, sensitivity, ruggedness and robustness were satisfactory for the method. The tablet sample of DFZN, VDGN, and MFMN was subjected to acid, water, base, sodium bisulfite, light, dry heat and peroxide degradations. Significant differences in retention times were observed between the well-resolved peaks of the degradants and the primary peaks (DFZN, VDGN, and MFMN). Thus, the assay might be characterised as stability indicating. The contents of DFZN, VDGN, and MFMN in dosage forms were assessed precisely and accurately by currently developed HPLC technique. This technique may be applied to ensure the quality of formulation doses for DFZN, VDGN, and MFMN contents.


Diabetes, Anti-Diabetic Molecules, Stability Indicating Assay, HPLC, Stress Degradation,


Download data is not yet available.


  1. M.Z. Banday, A.S. Sameer, S. Nissar, Pathophysiology of diabetes: An overview. Avicenna Journal of Medicine, 10(4), (2020) 174-188. https://doi.org/10.4103/ajm.ajm_53_20
  2. Y. Zheng, S.H. Ley, F.B. Hu, Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology, 14(2), (2018) 88-98. https://doi.org/10.1038/nrendo.2017.151
  3. R. Unnikrishnan, R.M. Anjana, V. Mohan, Diabetes mellitus and its complications in India. Nature Reviews Endocrinology, 12(6), (2016) 357-370. https://doi.org/10.1038/nrendo.2016.53
  4. P. Farmaki, C. Damaskos, N. Garmpis, A. Garmpi, S. Savvanis, E. Diamantis, Complications of the type 2 diabetes mellitus. Current Cardiology Reviews, 16(4), (2020) 249-251. http://dx.doi.org/10.2174/1573403X1604201229115531
  5. K. Papatheodorou, M. Banach, E. Bekiari, M. Rizzo, M. Edmonds, Complications of diabetes 2017. Journal of Diabetes Research, 2018, (2018) 3086167. https://doi.org/10.1155/2018/3086167
  6. Good to know: factors affecting blood glucose. Clinical Diabetes, 36(2), (2018) 202.
  7. American diabetes association, Diagnosis and classification of diabetes mellitus. Diabetes Care, 33 (Suppl 1), (2010) S62-S69. https://doi.org/10.2337/dc10-S062
  8. S. Kalra, A.K. Das, G. Priya, S. Ghosh, R.N. Mehrotra, S. Das, P. Shah, S. Bajaj, V. Deshmukh, D. Sanyal, S. Chandrasekaran, D. Khandelwal, A. Joshi, T. Nair, F. Eliana, H. Permana, M.D. Fariduddin, P.K. Shrestha, D. Shrestha, S. Kahandawa, M. Sumanathilaka, A. Shaheed, A.A.Rahim, A. Orabi, A. Al-ani, W. Hussein, D. Kumar, K. Shaikh, Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel. Journal of Family Medicine and Primary Care, 9(11), (2020) 5450-5457. https://doi.org/10.4103/jfmpc.jfmpc_843_20
  9. S Srivastava, R. Sharma, (2023) Dapagliflozin + Metformin + Vildagliptin. www.1mg.com. [Online]. Available: https://www.1mg.com/generics/dapagliflozin-metformin-vildagliptin-510082
  10. Vildagliptin, (2024) Pubchem, National library of medicine, National Cental for Biotechnlogy Information.
  11. Metformin Hydrochloride, (2024) Pubchem, National library of medicine, National Cental for Biotechnlogy Information. [Online]. Available: https://pubchem.ncbi.nlm.nih.gov/compound/Metformin
  12. Dapagliflozin, (2024) Pubchem, National library of medicine, National Cental for Biotechnlogy Information, [Online]. Available: https://pubchem.ncbi.nlm.nih.gov/compound/Dapagliflozin
  13. O.G. Albarrán, F.J. Ampudia-Blasco, Dapagliflozin, the first SGLT-2 inhibitor in the treatment of type 2 diabetes. Medicina Clínica (Barc), 141 (Suppl 2), (2013) 36-43. https://doi.org/10.1016/S0025-7753(13)70062-9
  14. C. Mathieu, P. Kozlovski, P.M. Paldánius, J.E. Foley, V. Modgill, M. Evans, & C. Serban, Clinical safety and tolerability of vildagliptin - insights from randomised trials, observational studies and post-marketing surveillance. European Endocrinology, 13(2), (2017) 68-72.
  15. Z. Lv, Y. Guo, Metformin and its benefits for various diseases. Frontiers in Endocrinology (Lausanne), 11, (2020) 191. https://doi.org/10.3389/fendo.2020.00191
  16. G. Rena, D.G. Hardie, E.R. Pearson, The mechanisms of action of metformin. Diabetologia, 60(9), (2017) 1577-1585. https://doi.org/10.1007/s00125-017-4342-z
  17. H.M. Nimje, S.J. Pawar, M.N. Deodhar, Validated Stability-Indicating RP-HPLC method for daclatasvir in tablets. Turkish Journal of Pharmaceutical Sciences, 20(4), (2023) 218-225. https://doi.org/10.4274/tjps.galenos.2022.87393
  18. A. Gumieniczek, A. Berecka-Rycerz, Metabolism and chemical degradation of new antidiabetic drugs (Part II): A review of analytical approaches for analysis of gliptins. Biomedicines, 11(7), (2023) 1956. https://doi.org/10.3390/biomedicines11071956
  19. B.R. Nagulancha, K.R. Vandavasi, Stability-indicating method development and validation for quantitative estimation of organic impurities of the antidiabetic drug glipizide in drug substance and pharmaceutical dosage form using HPLC. Biomedical Chromatography, 37(11), (2023) e5727. https://doi.org/10.1002/bmc.5727
  20. A. Azhakesan, S. Kuppusamy, Analytical quality by design-assisted HPLC method for quantification of canagliflozin and stability studies. ACS Omega, 8(8), (2023) 7407-7414. https://doi.org/10.1021/acsomega.2c06038
  21. F. Hameedat, S. Hawamdeh, S. Alnabulsi, A. Zayed, High performance liquid chromatography (HPLC) with fluorescence detection for quantification of steroids in clinical, pharmaceutical, and environmental samples: A review. Molecules, 27(6), (2022) 1807. https://doi.org/10.3390/molecules27061807
  22. Y.L. Chew, M.A. Khor, Y.Y. Lim, Choices of chromatographic methods as stability indicating assays for pharmaceutical products: A review. Heliyon, 7(3), (2021) e06553. https://doi.org/10.1016/j.heliyon.2021.e06553
  23. J.D. Hofer, B.A. Olsen, E.C. Rickard, Is HPLC assay for drug substance a useful quality control attribute?. Journal of Pharmaceutical and Biomedical Analysis, 44(4), (2007) 906-913. https://doi.org/10.1016/j.jpba.2007.04.023
  24. I.H.T. Guideline (2003). Stability testing of new drug substances and products Q1A (R2), current step, 4(1-24).
  25. ICH Harmonized tripartite guideline Q1A (R1), Validation of analytical procedures technical requirements for registration of pharmaceuticals for human use, Geneva, 2005.
  26. M.M. Hadir, A.E. Abdelrahman, N.Z. Alzoman, H.I. Aljohar, Stability-indicating capillary electrophoresis method for the simultaneous determination of metformin hydrochloride, saxagliptin hydrochloride, and dapagliflozin in pharmaceutical tablets. Journal of Liquid Chromatography & Related Technologies, 42 (5-6), (2019) 161-171. https://doi.org/10.1080/10826076.2019.1590208
  27. A.E. Afnan, M.M. Hadir, A.Z. Nourah, HPTLC method for the determination of metformin hydrochloride, saxagliptin hydrochloride, and dapagliflozin in pharmaceuticals. Current Analytical Chemistry, 16(5), (2020) 609-619. http://dx.doi.org/10.2174/1573407215666190131123029
  28. D.B. Sen, S. Jatu, R.A. Maheshwari, A.S. Zanwar, R. Velmurugan, A.K. Sen, New Eco-friendly UV-spectroscopic methods for simultaneous assessment of dapagliflozin, saxagliptin and metformin in ternary mixture. Indian Journal of Pharmaceutical Education and Research, 57(2), (2023) 559-569. https://doi.org/10.5530/ijper.57.2.69
  29. P. Barbude, M. Tawar, P. Burange, Method development using a UV Visible spectrophotometer for the simultaneous estimation of metformin (MET), Saxagliptin (SXG), and dapagliflozin (DGF) in marketed formulation. Asian Journal of Pharmaceutical Analysis. 12(4), (2022) 243-247. https://doi.org/10.52711/2231-5675.2022.00039
  30. K.R.Vankalapati, P. Alegete, S. Boodida, Stability-indicating HPLC method development and validation for simultaneous estimation of metformin, dapagliflozin, and saxagliptin in bulk drug and pharmaceutical dosage form. Biomedical chromatography, 36(7), (2022) e5384. https://doi.org/10.1002/bmc.5384
  31. D.S. Nandre, A. Ahmed, G.J. Khan, Stability indicating HPLC method development and validation for simultaneous estimation of dapagliflozin and metformin tablet dosage form. Asian Journal of Pharmaceutical and Clinical Research, 15(10), (2022) 109-114. https://doi.org/10.22159/ajpcr.2022.v15i10.45616
  32. P.K.C. Reddy, P. Mathur, A QBD driven analytical method development and validation of metformin and dapagliflozin by using reverse phase-high performance liquid chromatography. International Journal of Health Sciences, 6(S4), (2022) 8237–8248. https://doi.org/10.53730/ijhs.v6nS4.10505
  33. N.S. Dighe, P.R. Varade, G.S. Shinde, P.S. Rao. Quantitative estimation and validation of dapagliflozin and metformin hydrochloride in pharmaceutical dosage form by RP-HPLC. Asian Journal of Research in Chemistry, 12(3), (2019) 136-142. http://dx.doi.org/10.5958/0974-4150.2019.00028.2
  34. S. Nasser, I. Salama, S.M. Mostafa, M.S. Elgawish, Comparative high-performance liquid chromatographic and high-performance thin-layer chromatographic study for the simultaneous determination of dapagliflozin and metformin hydrochloride in bulk and pharmaceutical formulation. Journal of Planar Chromatography - Modern TLC, 31(6), (2018) 469-476. https://doi.org/10.1556/1006.2018.31.6.7
  35. B.R. Jani, K.V. Shah, P.P. Kapupara, Development and validation of UV spectroscopic method for simultaneous estimation of dapagliflozin and metformin hydrochloride in synthetic mixture. International Journal of Research and Development in Pharmacy and Life Sciences, 4(3), (2015) 1569-1576.